O
BLUE

OppenheimerFunds’s bluebird bio BLUE Stock Holding History

OppenheimerFunds’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$140M Buy
68,920
+6,594
+11% +$11.6M 0.17% 131
2018
Q4 		$80.1M Buy
62,326
+1,266
+2% +$1.94M 0.11% 181
2018
Q3 		$115M Sell
61,060
-247
-0.4% -$510K 0.13% 173
2018
Q2 		$125M Buy
61,307
+1,777
+3% +$4.05M 0.15% 163
2018
Q1 		$132M Sell
59,530
-14,712
-20% -$37.4M 0.16% 146
2017
Q4 		$171M Sell
74,242
-500
-0.7% -$1.02M 0.21% 127
2017
Q3 		$133M Sell
74,742
-700
-0.9% -$978K 0.16% 151
2017
Q2 		$103M Buy
75,442
+376
+0.5% +$454K 0.13% 187
2017
Q1 		$88.4M Buy
75,066
+68
+0.1% +$69.4K 0.11% 205
2016
Q4 		$59.9M Buy
74,998
+14,157
+23% +$11.2M 0.08% 275
2016
Q3 		$53.4M Sell
60,841
-43,559
-42% -$31.6M 0.07% 303
2016
Q2 		$58.5M Buy
104,400
+3,184
+3% +$1.8M 0.08% 284
2016
Q1 		$55.7M Sell
101,216
-404
-0.4% -$248K 0.07% 281
2015
Q4 		$84.5M Buy
101,620
+14,578
+17% +$14.6M 0.11% 204
2015
Q3 		$96.5M Buy
87,042
+33,901
+64% +$61.8M 0.13% 191
2015
Q2 		$116M Sell
53,141
-1,311
-2% -$2.67M 0.13% 187
2015
Q1 		$85.2M Sell
54,452
-3,646
-6% -$4.81M 0.1% 240
2014
Q4 		$69M Buy
+58,098
New +$38.8M 0.08% 277

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OppenheimerFunds's BLUE Position: Q1 2019 in Review

OppenheimerFunds increased its bluebird bio (BLUE) stake by 11% in Q1 2019, buying an estimated $11.6M and bringing the position to 68,920 shares worth $140M. The position accounts for 0.17% of the portfolio, ranked #131.

OppenheimerFunds first reported a position in BLUE in Q4 2014 and has held it in 18 quarters since. The position peaked at $171M in Q4 2017. 288 funds tracked by Wall St. Rank hold BLUE as of Q1 2019.

  • OppenheimerFunds held 68,920 shares of bluebird bio worth $140M as of Q1 2019.
  • OppenheimerFunds bought 6,594 bluebird bio shares in Q1 2019, an estimated $11.6M.
  • bluebird bio made up 0.17% of OppenheimerFunds's portfolio in Q1 2019, its #131 holding.
  • OppenheimerFunds first reported a position in bluebird bio in Q4 2014 and has held it in 18 quarters since.
  • OppenheimerFunds's bluebird bio position peaked at $171M in Q4 2017.
  • 288 funds tracked by Wall St. Rank held bluebird bio as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.